日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Understanding the symptoms and impacts of living with metastatic pancreatic adenocarcinoma: a prospective, noninterventional qualitative study

了解转移性胰腺腺癌患者的症状和生活影响:一项前瞻性、非干预性定性研究

Oh, Mok; Chang, Lawrence; Matney, Cassandra; Fuldeore, Rupali; Perez, Eyra; Alici, Yesne; Buzaglo, Joanne; Mao, Michelle; Park, Wungki

Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study

关于佐贝妥昔单抗联合化疗患者恶心呕吐预防和管理的共识指南:RAND/UCLA改良德尔菲专家组研究

Klempner, S J; Pazo-Cid, R A; Lonardi, S; Swanson, L; Arango, M J; Enzinger, P; Ko, A H; Vaccaro, G M; Yamaguchi, K; Saeed, A; Lee, K-W; Shitara, K; Ilson, D; Ajani, J A; Fuldeore, R; Braun, S; Broder, M S; Shah, M A

Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

更正:乌帕替尼可改善对传统合成疾病修饰抗风湿药物反应不足的类风湿关节炎患者的患者报告结局:SELECT-NEXT 研究结果

Strand, Vibeke; Pope, Janet; Tundia, Namita; Friedman, Alan; Camp, Heidi S; Pangan, Aileen; Ganguli, Arijit; Fuldeore, Mahesh; Goldschmidt, Debbie; Schiff, Michael

Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case-Control Cohort Analysis

抑郁症合并膀胱过度活动症患者的医疗资源利用率及直接和间接成本增加:一项回顾性匹配病例对照队列分析的证据

Shiozawa, Aki; Hopson, Sari; Fuldeore, Rupali; Stoelzel, Matthias; Ng, Daniel; Hairston, John

Direct Costs Incurred Among Women Undergoing Surgical Procedures to Treat Uterine Fibroids

接受子宫肌瘤手术治疗的女性所产生的直接费用

Harrington, Amanda; Bonine, Nicole G; Banks, Erika; Shih, Vanessa; Stafkey-Mailey, Dana; Fuldeore, Rupali M; Yue, Binglin; Ye, Jiatao Michael; Ta, Jamie T; Gillard, Patrick

Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs

乌帕替尼对患者报告结局的影响:SELECT-BEYOND 研究结果,这是一项针对对生物制剂类疾病修饰抗风湿药物反应不足的类风湿关节炎患者的 3 期随机试验。

Strand, Vibeke; Schiff, Michael; Tundia, Namita; Friedman, Alan; Meerwein, Sebastian; Pangan, Aileen; Ganguli, Arijit; Fuldeore, Mahesh; Song, Yan; Pope, Janet

Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT

Upadacitinib 可改善对传统合成疾病修饰抗风湿药物反应不足的类风湿关节炎患者的患者报告结局:SELECT-NEXT 研究结果

Strand, Vibeke; Pope, Janet; Tundia, Namita; Friedman, Alan; Camp, Heidi S; Pangan, Aileen; Ganguli, Arijit; Fuldeore, Mahesh; Goldschmidt, Debbie; Schiff, Michael

Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis

类风湿性关节炎患者对靶向免疫调节剂反应不足的经济负担

Strand, Vibeke; Tundia, Namita; Song, Yan; Macaulay, Dendy; Fuldeore, Mahesh

Chronic kidney disease in gout in a managed care setting

在医疗管理机构中,慢性肾脏病合并痛风

Fuldeore, Mahesh J; Riedel, Aylin A; Zarotsky, Victoria; Pandya, Bhavik J; Dabbous, Omar; Krishnan, Eswar